Searched for: in-biosketch:true
person:wolfgc01
Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection" [Comment]
Margonis, Georgios Antonios; Andreatos, Nikolaos; Wolfgang, Christopher L; Weiss, Matthew J
PMID: 29864095
ISSN: 1528-1140
CID: 4740772
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group
Ecker, Brett L; McMillan, Matthew T; Allegrini, Valentina; Bassi, Claudio; Beane, Joal D; Beckman, Ross M; Behrman, Stephen W; Dickson, Euan J; Callery, Mark P; Christein, John D; Drebin, Jeffrey A; Hollis, Robert H; House, Michael G; Jamieson, Nigel B; Javed, Ammar A; Kent, Tara S; Kluger, Michael D; Kowalsky, Stacy J; Maggino, Laura; Malleo, Giuseppe; Valero, Vicente; Velu, Lavanniya K P; Watkins, Amarra A; Wolfgang, Christopher L; Zureikat, Amer H; Vollmer, Charles M
OBJECTIVE:To identify a clinical fistula risk score following distal pancreatectomy. BACKGROUND:Clinically relevant pancreatic fistula (CR-POPF) following distal pancreatectomy (DP) is a dominant contributor to procedural morbidity, yet risk factors attributable to CR-POPF and effective practices to reduce its occurrence remain elusive. METHODS:This multinational, retrospective study of 2026 DPs involved 52 surgeons at 10 institutions (2001-2016). CR-POPFs were defined by 2016 International Study Group criteria, and risk models generated using stepwise logistic regression analysis were evaluated by c-statistic. Mitigation strategies were assessed by regression modeling while controlling for identified risk factors and treating institution. RESULTS:CR-POPF occurred following 306 (15.1%) DPs. Risk factors independently associated with CR-POPF included: age (<60 yrs: OR 1.42, 95% CI 1.05-1.82), obesity (OR 1.54, 95% CI 1.19-2.12), hypoalbuminenia (OR 1.63, 95% CI 1.06-2.51), the absence of epidural anesthesia (OR 1.59, 95% CI 1.17-2.16), neuroendocrine or nonmalignant pathology (OR 1.56, 95% CI 1.18-2.06), concomitant splenectomy (OR 1.99, 95% CI 1.25-3.17), and vascular resection (OR 2.29, 95% CI 1.25-3.17). After adjusting for inherent risk between cases by multivariable regression, the following were not independently associated with CR-POPF: method of transection, suture ligation of the pancreatic duct, staple size, the use of staple line reinforcement, tissue patches, biologic sealants, or prophylactic octreotide. Intraoperative drainage was associated with a greater fistula rate (OR 2.09, 95% CI 1.51-3.78) but reduced fistula severity (P < 0.001). CONCLUSIONS:From this large analysis of pancreatic fistula following DP, CR-POPF occurrence cannot be reliably predicted. Opportunities for developing a risk score model are limited for performing risk-adjusted analyses of mitigation strategies and surgeon performance.
PMID: 28857813
ISSN: 1528-1140
CID: 4740402
Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway Discussion [Editorial]
Adams, David B.; Lillemoe, Keith D.; Wolfgang, Christopher; Vickers, Selwyn; Shoup, Margo; Hughes, Marybeth; Lavu, Harish
ISI:000461357100017
ISSN: 1072-7515
CID: 4744922
Variation in the surgical management of locally advanced pancreatic cancer. [Meeting Abstract]
Reames, Bradley Norman; Blair, Alex; Krell, Robert Wallace; Padussis, James; Thayer, Sarah P.; Falconi, Massimo; Wolfgang, Christopher Lee; Weiss, Matthew J.; Are, Chandrakanth; He, Jin
ISI:000487345805309
ISSN: 0732-183x
CID: 4745032
Prognostic Impact of KRAS Mutational Status in Patients with Colorectal Cancer Liver Metastases Differs According to the Location of the Primary Tumor [Meeting Abstract]
Amini, Neda; Margonis, Georgios Antonios; Kreis, Martin E.; Poultsides, George A.; Sasaki, Kazunari; Wagner, Doris; Pikoulis, Emmanouil; Weiss, Matthew J.; Wolfgang, Christopher L.; Safar, Bashar
ISI:000492740900114
ISSN: 1072-7515
CID: 4745062
NON-SELECTIVE beta-ADRENERGIC BLOCKADE IMPACTS PANCREATIC CANCER TUMOR BIOLOGY, DECREASES PERINEURAL INVASION AND IMPROVES PATIENT SURVIVAL [Meeting Abstract]
Blair, Alex; Jurcak, Noelle; Javed, Ammar A.; Teinor, Jonathan; Rozich, Noah; Groot, Vincent P.; Cameron, John; Weiss, Matthew J.; He, Jin; Wolfgang, Christopher L.; Zheng, Lei; Burkhart, Richard
ISI:000467106005414
ISSN: 0016-5085
CID: 5373032
Analysis of spatial relationships between infiltrating immune cells within the tumor microenvironment following combinatorial immunotherapy [Meeting Abstract]
Thomas, Dwayne L., II; Murphy, Adrian G.; Weiss, Matthew J.; He, Jin; Makary, Martin A.; Burkhart, Richard A.; Wolfgang, Christopher L.; Jaffee, Elizabeth M.; Zheng, Lei; Thompson, Elizabeth D.
ISI:000488279402050
ISSN: 0008-5472
CID: 4745052
Development of Diabetes after Pancreaticoduodenectomy: Results of a 10-Year Series Using Prospective Endocrine Evaluation Discussion [Editorial]
Wolfgang, Christopher; Adams, David; Yeo, Charles J.; Jones, R. Scott; Sarmiento, Juan
ISI:000461357100015
ISSN: 1072-7515
CID: 4744912
Post-Pancreaticoduodenectomy Outcomes and Epidural Analgesia: A 5-year Single-Institution Experience Discussion [Editorial]
Sarmiento, Juan; Adams, David B.; Hayes-Jordan, Andrea; Hughes, Marybeth; Page, Andrew; Wolfgang, Christopher; Lillemoe, Keith D.; Schmidt, C. Max
ISI:000461357100023
ISSN: 1072-7515
CID: 4744932
A Phase II clinical trial of GVAX pancreas vaccine (with Cyclophosphamide) in combination with Nivolumab and Stereotactic Body Radiation Therapy (SBRT) followed by definitive resection for patients with borderline resectable pancreatic adenocarcinoma (BR-PDAC) [Meeting Abstract]
Osipov, Arsen; Sugar, Elizabeth; Ferguson, Anna; Durham, Jennifer; Rodriguez, Christina; Parkinson, Rose; Sena, Laura; Zheng, Lei; Wolfgang, Christopher; Burkhart, Richard; He, Jin; Weiss, Matthew; Narang, Amol; Laheru, Daniel; Azad, Nilofer; Jaffee, Elizabeth; Weekes, Colin; Yarchoan, Mark
ISI:000488129900146
ISSN: 0008-5472
CID: 4745042